According to a newly published market research report by 24LifeSciences, global drugs for schistosomiasis market was valued at USD 80.6 million in 2024 and is projected to reach USD 106.0 million by 2032, growing at a compound annual growth rate (CAGR) of 4.1% during the forecast period 2025–2032. Schistosomiasis, commonly referred to as bilharzia or snail fever, is a neglected...

According to a newly published market research report by 24LifeSciences, the global Lamellar Ichthyosis Treatment market was valued at USD 450 million in 2024 and is projected to reach USD 680 million by 2032, growing at a compound annual growth rate (CAGR) of 5.3% during the forecast period 2025–2032. Lamellar Ichthyosis (LI) is a rare, severe genetic skin disorder caused primarily...

According to a newly published market research report by 24LifeSciences, the global opiate antagonist market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.3 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.1% during the forecast period 20252032. Opiate antagonists such as naloxone and naltrexone have become critical therapeutic agents in addressing...

According to a newly published market research report by 24LifeSciences, global varicella vaccine market was valued at USD 4.13 billion in 2024 and is projected to reach USD 7.20 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.4% during the forecast period 2025–2032. Varicella vaccine, clinically known as the chickenpox vaccine, is a highly effective...

Arthropod-borne viral infections continue to pose significant public health challenges across both developed and developing regions. The growing prevalence of mosquito, tick, and other vector-transmitted diseases has increased the demand for advanced diagnostic technologies that enable rapid and accurate detection. The Arthropod-Borne Viral Infections Testing Market Size was valued at US$ 1.54...

Gastric antisecretory drugs play a crucial role in managing acid-related gastrointestinal disorders, including gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. These medications help reduce gastric acid production, thereby improving patient outcomes and quality of life. Rising prevalence of digestive disorders and increasing awareness regarding effective...

North America holds a notable share of the human rabies immunoglobulin market, driven by high awareness regarding rabies prevention, robust healthcare spending, and established treatment guidelines for post-exposure prophylaxis. The region benefits from strong pharmaceutical manufacturing capabilities, advanced healthcare facilities, and ongoing public health initiatives focused on infectious...

 According to a newly published market research report by 24LifeSciences, the global opiate antagonist market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.3 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.1% during the forecast period 20252032. Opiate antagonists such as naloxone and...

According to a newly published market research report by 24LifeSciences, global skin cancer diagnostics and therapeutics market was valued at USD 8.9 billion in 2024 and is projected to reach USD 15.3 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.8% during the forecast period 2025–2031. Skin cancer diagnostics and therapeutics encompass the comprehensive suite...

According to a newly published market research report by 24LifeSciences, the global thyroid cancer testing market was valued at USD 1.63 billion in 2024 and is projected to reach USD 2.84 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025–2031. Thyroid cancer testing encompasses a comprehensive suite of diagnostic procedures essential...